Rabloc

Hypolipemiant. IHMG-CoA reductase inhibitor. Indicated to treat hypercholesterolemia, dyslipidemias, dysbetalipoproteinemia and for the prevention of more severe cardiovascular events in patients at high cardiovascular risk.

Therapeutic Area
Leukotriene Receptor Antagonist + Hypolipemiant HMG-CoA reductase inhibitor

Active Ingredient
Rosuvastatine

Line
Cardiometabolism

Pharmaceutical Forms
10 mg coated tablets x 30
20 mg coated tablets x 30

Download Leaflet Descargar